RCAI-56 is a synthetic glycolipid exhibiting a potent antitumor activity by stimulation
of natural killer T cells. Tetra-O-benzyl-α-carbagalactose, an important synthetic segment of RCAI-56, was stereoselectively
synthesized from 1,4-dichloro-2-butene in nine steps, including the key step of organocatalytic
asymmetric Diels–Alder reaction between acrolein and 1-benzyloxybutadiene.
Key words
α-carbagalactose - glycolipid - RCAI-56 - Diels–Alder reaction - organocatalyst